Autonomic Nervous System Dysfunction
Autonomic dysfunction is nearly universal in ME/CFS and contributes substantially to disability. The NIH deep phenotyping study provided quantitative documentation of specific autonomic abnormalities (Walitt et al. 2024).
1 Sympathetic vs. Parasympathetic Imbalance
1.1 Heart Rate Variability Studies
Heart rate variability (HRV) provides a non-invasive window into autonomic function. The NIH study documented significantly diminished HRV in PI-ME/CFS patients compared to controls (Walitt et al. 2024). These changes included reduced overall variability (lower standard deviation of NN intervals or SDNN, reflecting decreased overall autonomic modulation), diminished high-frequency power (reduced HF-HRV, specifically reflecting decreased parasympathetic or vagal activity), altered low-frequency power (changes in LF-HRV, influenced by both sympathetic and parasympathetic activity), and abnormal LF/HF ratio (suggesting sympathovagal imbalance).
Clinical Implications of Reduced HRV Diminished HRV in ME/CFS correlates with greater fatigue severity (Escorihuela et al., n=45: RMSSD p=0.027, HFnu p=0.007 (Escorihuela et al. 2020)), worse orthostatic intolerance, impaired cognitive function, reduced exercise capacity, and poorer quality of life.
Low HRV is also an independent predictor of cardiovascular morbidity and mortality in other populations, raising concerns about long-term cardiovascular outcomes in ME/CFS.
1.2 Baroreflex Sensitivity
The baroreflex maintains blood pressure stability through rapid adjustments in heart rate and vascular tone. The NIH study found diminished baroreflex cardiovagal gain in ME/CFS patients (Walitt et al. 2024), indicating impaired ability to modulate heart rate in response to blood pressure changes, reduced parasympathetic responsiveness, delayed cardiovascular adaptation to postural changes, and vulnerability to orthostatic stress.
Baroreflex Testing Methods Several methods assess baroreflex function. Spontaneous baroreflex analysis calculates the relationship between spontaneous blood pressure and R-R interval fluctuations. The Valsalva maneuver assesses heart rate and blood pressure responses to standardized straining. Neck suction or pressure directly stimulates carotid baroreceptors, while pharmacological methods use vasoactive drugs to manipulate blood pressure.
1.3 Evidence for Decreased Parasympathetic Activity
Multiple lines of evidence converge on parasympathetic (vagal) dysfunction as a central feature of ME/CFS autonomic abnormalities. Reduced HRV high-frequency power provides a direct measure of cardiac vagal modulation. Diminished baroreflex sensitivity, which is primarily mediated by vagal mechanisms, further supports this dysfunction. Pupillary abnormalities reveal altered pupil responses to light (parasympathetically mediated — see Section Key Biomarkers from the NIH Deep Phenotyping Study for the mechanistic basis and cross-disease evidence), while gastrointestinal dysmotility reflects vagal nerve dysregulation of gut function. Additionally, reduced respiratory sinus arrhythmia indicates impaired vagally mediated heart rate variation with breathing.
The NIH study explicitly concluded that the autonomic findings indicated “decreased parasympathetic activity” (Walitt et al. 2024), providing a unifying explanation for many ME/CFS symptoms.
1.4 Sympathetic Nervous System Abnormalities
While parasympathetic dysfunction is prominent, sympathetic abnormalities also occur. Resting sympathetic overactivity manifests as elevated norepinephrine spillover and increased muscle sympathetic nerve activity. Despite this elevated baseline, sympathetic reactivity is impaired, showing blunted responses to stressors. Regional sympathetic dysfunction produces variable activation across different vascular beds, while catecholamine dysregulation affects synthesis, release, and clearance.
Reconciling central vs. peripheral norepinephrine: An apparent contradiction exists between reduced central (CNS) norepinephrine documented in CSF (Walitt et al. 2024) and elevated peripheral norepinephrine spillover. This likely reflects compartmentalization: central noradrenergic systems (locus coeruleus, brain norepinephrine) are separate from peripheral sympathetic nervous system activity. One proposed mechanism is that central deficiency could plausibly impair the brain’s regulation of the sympathetic nervous system, leading to dysregulated peripheral sympathetic output—elevated at rest but unable to respond appropriately to challenges. This dissociation between central and peripheral catecholamine compartments is well-established in autonomic physiology.
The combination of elevated baseline sympathetic activity with reduced reactivity creates a rigid, poorly adaptive autonomic system unable to respond appropriately to physiological challenges.
2 Mechanisms of Orthostatic Intolerance
Orthostatic intolerance (OI) affects an estimated 70–90% of ME/CFS patients and manifests as postural orthostatic tachycardia syndrome (POTS), neurally mediated hypotension (NMH), orthostatic hypotension (OH), or combinations of these conditions.
Dysautonomia and POTS are components of the “Septad” framework of frequently co-occurring conditions in ME/CFS (Section Prospective Phenotyping as Harm Reduction). Small fiber neuropathy, another Septad component, may underlie autonomic dysfunction in a subset of patients, emphasizing the need for comprehensive evaluation of these interrelated pathophysiologies.
2.1 Blood Volume Abnormalities
Reduced blood volume is well-documented in ME/CFS and contributes to orthostatic intolerance (Streeten and Bell 1998). Streeten and Bell documented that red blood cell mass was significantly reduced (p<0.001) in 93.8% of female patients and 50% of male patients, with plasma volume subnormal in 52.6%. This total blood volume decrease compromises cardiovascular reserve through mechanisms possibly involving renin-angiotensin-aldosterone system dysfunction, reduced erythropoietin, or increased capillary permeability.
Hypovolemia reduces cardiac preload, compromising stroke volume and cardiac output, particularly during orthostatic stress.
2.2 Vascular Dysfunction
Multiple vascular abnormalities contribute to orthostatic intolerance. Impaired venoconstriction reduces the ability to mobilize venous blood during standing, leading to excessive venous pooling as blood accumulates in dependent vessels. Arterial dysregulation produces abnormal resistance vessel responses, while endothelial dysfunction impairs nitric oxide bioavailability.
2.3 Adrenergic Receptor Dysfunction
Abnormalities in adrenergic receptor function may explain some autonomic symptoms. Beta-adrenergic receptor autoantibodies have been identified in subsets of ME/CFS patients (Loebel et al. 2016) and may either activate or block receptors. Loebel et al. found that 29.5% of ME/CFS patients (n=268) had elevated autoantibodies against \(\beta\) 2, M3, and/or M4 receptors. Antibodies against \(\beta\) 2 adrenergic and M3 muscarinic receptors (both vasodilators) could explain vasoconstriction and hypoxemia observed in ME/CFS. Alpha-adrenergic abnormalities produce altered vasoconstrictor responses, while receptor desensitization may result from chronic catecholamine exposure downregulating receptors. Additionally, post-receptor signaling defects in G-protein coupling or second messenger systems may contribute to dysfunction.
2.4 Renin-Angiotensin-Aldosterone System
The RAAS regulates blood volume and pressure through sodium and water retention, vasoconstriction, and sympathetic activation.
Abnormalities in ME/CFS may include reduced aldosterone response to orthostatic stress, impaired renin secretion, altered angiotensin II sensitivity, and inappropriate natriuresis.